FDA Adverse Event Injury Summary report: N

SINGLE USE 3-LUMEN SPHINCTEROTOME V

MDR report key: 22929232 · Received August 29, 2025

Report

Report Number
2429304-2025-00238
Event Type
Injury
Date Received
August 29, 2025
Date of Event
February 10, 2020
Report Date
August 29, 2025
Manufacturer
AOMORI OLYMPUS CO., LTD.
Product Code
KNS
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED "EFFICACY OF SINGLE-OPERATOR CHOLANGIOSCOPY-GUIDED LITHOTRIPSY COMPARED WITH LARGE BALLOON SPHINCTEROPLASTY IN MANAGEMENT OF DIFFICULT BILE DUCT STONES IN A RANDOMIZED TRIAL." BACKGROUND AND AIMS: ALTHOUGH SINGLE-OPERATOR CHOLANGIOSCOPY (SOC)-GUIDED LITHOTRIPSY AND LARGE BALLOON SPHINCTEROPLASTY (LBS)-BASED TECHNIQUES ARE EFFECTIVE RESCUE MEASURES, THE IDEAL APPROACH TO MANAGEMENT OF DIFFICULT BILE DUCT STONES IS UNCLEAR. WE CONDUCTED A RANDOMIZED TRIAL TO COMPARE THE EFFECTIVENESS OF SOC-GUIDED LITHOTRIPSY AND LBS-BASED APPROACHES FOR ENDOSCOPIC MANAGEMENT OF DIFFICULT BILE DUCT STONES. METHODS: PATIENTS WITH DIFFICULT BILE DUCT STONES WHO FAILED RETRIEVAL USING BALLOON OR BASKET WERE RANDOMLY ASSIGNED TO GROUPS THAT RECEIVED SOC-GUIDED LASER LITHOTRIPSY (SOC-LL, N [33) OR LBS (N [ 33), FROM (B)(6) 2018. WHEN ASSIGNED TREATMENT WAS UNSUCCESSFUL, PATIENTS UNDERWENT MECHANICAL LITHOTRIPSY BEFORE CROSSING OVER TO THE OTHER GROUP. THE MAIN OUTCOME WAS TREATMENT SUCCESS, DEFINED AS ABILITY TO CLEAR THE DUCT IN 1 SESSION. SECONDARY OUTCOMES WERE ADVERSE EVENTS AND TREATMENT COSTS. RESULTS: A HIGHER PROPORTION OF PATIENTS IN THE SOC-LL GROUP HAD TREATMENT SUCCESS (93.9%) THAN IN THE LBS GROUP (72.7%; P [ .021). ON MULTIPLE LOGISTIC REGRESSION ANALYSIS, TREATMENT SUCCESS WAS SIGNIFICANTLY ASSOCIATED WITH USE OF SOC-LL (ODDS RATIO [OR], 8.7; 95% CI, 1.3¿59.3; P [ .026), STONE TO EXTRAHEPATIC BILE DUCT RATIO OF 1 OR LESS (OR, 28.8; 95% CI, 1.2¿687.6; P [ .038), AND LACK OF A TAPERED BILE DUCT (OR, 26.9; 95% CI, 1.3¿558.2; P [ .034). THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN GROUPS IN ADVERSE EVENTS (9.1% IN THE SOC-LL GROUP VS 3.0% IN THE LBS GROUP, P [ .61) OR OVERALL TREATMENT COST ($16,684 IN THE SOC-LL GROUP VS $10,626 IN THE LBS GROUP; P [ .097). TYPE OF ADVERSE EVENTS/NUMBER OF PATIENTS CRICOPHARYNGEAL PERFORATION (1 PATIENT) BILE PERITONITIS CAUSED BY PERFORATION IN THE DISTAL BILE DUCT AFTER LASER LITHOTRIPSY (1 PATIENT) MILD POST-ERCP PANCREATITIS (1 PATIENT) MODERATE SEVERITY POST-ERCP PANCREATITIS (1 PATIENT). CONCLUSION: IN A RANDOMIZED TRIAL OF PATIENTS WITH DIFFICULT BILE STONES THAT CANNOT BE CLEARED BY STANDARD MANEUVERS, SOC-GUIDED LITHOTRIPSY LEADS TO DUCT CLEARANCE IN A SIGNIFICANTLY HIGHER PROPORTION OF PATIENTS THAN LBS-PARTICULARLY WHEN STONE SIZE EXCEEDS THE DIAMETER OF THE EXTRAHEPATIC BILE DUCT. ADJUNCT LITHOTRIPSY MIGHT BE REQUIRED IN PATIENTS WITH TAPERED DISTAL BILE DUCT, BECAUSE LBS ALONE IS LESS LIKELY TO BE SUCCESSFUL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2222982 SINGLE USE 3-LUMEN SPHINCTEROTOME V SINGLE USE 2-LUMEN SPHINCTEROTOME KNS AOMORI OLYMPUS CO., LTD. KD-V411M-0725 NI

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention B-V232P-A| FG-V422PR| G-260-2545A| TJF-Q180V